Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence
By Elana Gotkine HealthDay Reporter

WEDNESDAY, June 18, 2025 -- In coastal counties, marine microplastic levels (MMLs) are associated with the prevalence of cardiometabolic diseases, according to a study published online June 18 in the Journal of the American Heart Association.
Bhargav Makwana, M.D., from the Lahey Hospital & Medical Center in Burlington, Massachusetts, and colleagues geospatially analyzed microplastic concentration data within 200 nautical miles of the U.S. coastline to calculate mean MMLs. The coastal counties were stratified into four categories: low, medium, high, or very high MMLs. The prevalence of type 2 diabetes, coronary artery disease, and stroke in these counties was examined using Behavioral Risk Factor Surveillance System 2019 to 2020 survey data, and the associations between disease prevalence and MMLs were examined.
The researchers found that compared with counties with low levels, counties with very high MMLs had an 18, 7, and 9 percent higher adjusted prevalence of type 2 diabetes, coronary artery disease, and stroke, respectively.
"This study adds to a growing body of evidence that the garbage we discard into the environment often finds its way back to us. It's time to shift from awareness to action," senior author Sarju Ganatra, M.D., also from Lahey Hospital & Medical Center, said in a statement. "We urge policymakers to view plastic pollution as an environmental crisis as well as a potential health crisis."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-19 06:00
Read more

- Doctors' Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
- New Blood Test Promises Pain-Free Diagnosis Of Celiac Disease
- Digital Tool Potentially Predicts Childhood Asthma
- DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes
- Dementia Caregivers Themselves At Higher Risk For Brain Aging
- Misconceptions Abound Regarding High Blood Pressure, Poll Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions